These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2499547)

  • 1. Development of resistance to Trypanosoma cruzi in mice depends on a viable population of L3T4+ (CD4+) T lymphocytes.
    Araujo FG
    Infect Immun; 1989 Jul; 57(7):2246-8. PubMed ID: 2499547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi.
    Rizzo LV; Cunha-Neto E; Teixeira AR
    Infect Immun; 1989 Sep; 57(9):2640-4. PubMed ID: 2474498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies.
    Minoprio P; Eisen H; Joskowicz M; Pereira P; Coutinho A
    J Immunol; 1987 Jul; 139(2):545-50. PubMed ID: 2955044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.
    Hernández-Munaín C; De Diego JL; Alcina A; Fresno M
    J Exp Med; 1992 Jun; 175(6):1473-82. PubMed ID: 1375261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection.
    Curotto de Lafaille MA; Barbosa de Oliveira LC; Lima GC; Abrahamsohn IA
    Exp Parasitol; 1990 Feb; 70(2):164-74. PubMed ID: 2105229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of T-cell subpopulations in experimental Chagas' disease.
    Tarleton RL
    Res Immunol; 1991 Feb; 142(2):130-3. PubMed ID: 1678199
    [No Abstract]   [Full Text] [Related]  

  • 8. T Cell Specificity: A Great Challenge in Chagas Disease.
    Ferragut F; Acevedo GR; Gómez KA
    Front Immunol; 2021; 12():674078. PubMed ID: 34267750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
    Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and partial characterization of Trypanosoma cruzi antigens recognized by T cells and immune sera from patients with Chagas' disease.
    Gazzinelli RT; Leme VM; Cancado JR; Gazzinelli G; Scharfstein J
    Infect Immun; 1990 May; 58(5):1437-44. PubMed ID: 2108932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice.
    Araujo FG; Morein B
    Infect Immun; 1991 Sep; 59(9):2909-14. PubMed ID: 1908826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
    Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
    Front Immunol; 2020; 11():1279. PubMed ID: 32695105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific activation of CD4
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
    Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK1.1+ cells and T-cell activation in euthymic and thymectomized C57Bl/6 mice during acute Trypanosoma cruzi infection.
    Cardillo F; Cunha FQ; Tamashiro WM; Russo M; Garcia SB; Mengel J
    Scand J Immunol; 2002 Jan; 55(1):96-104. PubMed ID: 11841697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterisation of human T-cell lines from a patient with Chagas' disease.
    Britten V; Hudson L
    Lancet; 1985 Sep; 2(8456):637-9. PubMed ID: 2412080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigen.
    Rampazo EV; Amorim KN; Yamamoto MM; Panatieri RH; Rodrigues MM; Boscardin SB
    PLoS One; 2015; 10(2):e0117778. PubMed ID: 25679777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The flagellar fraction of Trypanosoma cruzi depleted of an immunosuppressive antigen enhances protection to infection and elicits spontaneous T cell responses.
    Hansen DS; Alievi G; Segura EL; Carlomagno M; Morein B; Villacres-Eriksson M
    Parasite Immunol; 1996 Dec; 18(12):607-15. PubMed ID: 9226699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi glycoprotein of M(r) 56,000 characterization and assessment of its potential to protect against fatal parasite infections.
    Harth G; Mills AA; Lin T; Araujo FG
    Mol Microbiol; 1994 Jan; 11(2):261-71. PubMed ID: 8170388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to Trypanosoma cruzi induced by immunization with antigens isolated by affinity chromatography.
    Araujo FG
    Braz J Med Biol Res; 1984; 17(2):157-64. PubMed ID: 6440611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.